Bck Capital Management LP Immunovant, Inc. Transaction History

Bck Capital Management LP

  • $289 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
BUY
$7.33 - $9.32 $6,113 - $7,772
834 Added 1.56%
54,293 $463,000
Q3 2021

Nov 09, 2021
BUY
$7.01 - $11.37 $92,686 - $150,334
13,222 Added 32.86%
53,459 $465,000
Q2 2021

Jul 20, 2021
BUY
$9.4 - $16.85 $83,754 - $150,133
8,910 Added 28.44%
40,237 $425,000
Q1 2021

May 06, 2021
BUY
$13.08 - $49.6 $409,757 - $1.55 Million
31,327 New
31,327 $502,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Bck Capital Management LP Portfolio

Follow Bck Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Bck Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email